140 related articles for article (PubMed ID: 19790151)
41. Allogeneic transplantation of G-CSF mobilized peripheral blood stem cells from unrelated donors: a retrospective analysis.
Bornhäuser M; Theuser C; Soucek S; Hölig K; Klingebiel T; Blau W; Fauser A; Runde V; Schwinger W; Rutt C; Ehninger G
Haematologica; 2000 Aug; 85(8):839-47. PubMed ID: 10942931
[TBL] [Abstract][Full Text] [Related]
42. Whole liver versus split liver versus living donor in the adult recipient: an analysis of outcomes by graft type.
Humar A; Beissel J; Crotteau S; Kandaswamy R; Lake J; Payne W
Transplantation; 2008 May; 85(10):1420-4. PubMed ID: 18497681
[TBL] [Abstract][Full Text] [Related]
43. Transplantation of liver grafts from older donors: impact on recipients with hepatitis C virus infection.
Jain A; Orloff M; Abt P; Kashyap R; Mohanka R; Lansing K; Bozorgzadeh A
Transplant Proc; 2005 Sep; 37(7):3162-4. PubMed ID: 16213337
[TBL] [Abstract][Full Text] [Related]
44. Model for End-Stage Liver Disease (MELD) system to allocate and to share livers: experience of two Italian centers.
Ravaioli M; Masetti M; Dazzi A; Romano A; Spaggiari M; Grazi GL; Ercolani G; Cescon M; Di Gioia P; De Ruvo N; Montalti R; Ballarin R; Di Benedetto F; Ridolfi L; Alvaro N; Ramacciato G; Morelli C; Gerunda E; Pinna AD
Transplant Proc; 2008; 40(6):1814-5. PubMed ID: 18675057
[TBL] [Abstract][Full Text] [Related]
45. Enhanced chemotherapy delivery by intraarterial infusion and blood-brain barrier disruption in malignant brain tumors: the Sherbrooke experience.
Fortin D; Desjardins A; Benko A; Niyonsega T; Boudrias M
Cancer; 2005 Jun; 103(12):2606-15. PubMed ID: 15880378
[TBL] [Abstract][Full Text] [Related]
46. Liver transplantation: an Australian experience.
Sheil AG; McCaughan GW; Thompson JF; Dorney SF; Stephen MS; Shun A; Bookallil MJ; Painter DM; Rickard K; Dolan PM
Clin Transpl; 1990; ():145-55. PubMed ID: 2103140
[TBL] [Abstract][Full Text] [Related]
47. Use of severely steatotic grafts in liver transplantation: a matched case-control study.
McCormack L; Petrowsky H; Jochum W; Mullhaupt B; Weber M; Clavien PA
Ann Surg; 2007 Dec; 246(6):940-6; discussion 946-8. PubMed ID: 18043095
[TBL] [Abstract][Full Text] [Related]
48. Central nervous system.
Adamson DC; Rasheed BA; McLendon RE; Bigner DD
Cancer Biomark; 2010; 9(1-6):193-210. PubMed ID: 22112477
[TBL] [Abstract][Full Text] [Related]
49. Establishment of a pediatric liver transplantation program: experience with 100 transplantation procedures.
Ciria R; Sánchez-Hidalgo JM; Briceño J; Naranjo A; Pleguezuelo M; Díaz-Nieto R; Luque A; Jiménez J; García-Menor E; Gilbert JJ; de la Mata M; Pérez-Navero JL; Solórzano G; Rufián S; Pera C; López-Cillero P
Transplant Proc; 2009; 41(6):2444-6. PubMed ID: 19715946
[TBL] [Abstract][Full Text] [Related]
50. Evaluation of donors for living donor liver transplantation (LDLT).
Sobhonslidsuk A; Intaraprasong P; Tongprasert S
J Med Assoc Thai; 2010 May; 93(5):637-41. PubMed ID: 20524455
[TBL] [Abstract][Full Text] [Related]
51. Advising potential recipients on the use of organs from donors with primary central nervous system tumors.
Warrens AN; Birch R; Collett D; Daraktchiev M; Dark JH; Galea G; Gronow K; Neuberger J; Hilton D; Whittle IR; Watson CJ;
Transplantation; 2012 Feb; 93(4):348-53. PubMed ID: 22258288
[TBL] [Abstract][Full Text] [Related]
52. Risk of tumor transmission after thoracic allograft transplantation from adult donors with central nervous system neoplasm-A UNOS database study.
Hynes CF; Ramakrishnan K; Alfares FA; Endicott KM; Hammond-Jack K; Zurakowski D; Jonas RA; Nath DS
Clin Transplant; 2017 Apr; 31(4):. PubMed ID: 28135779
[TBL] [Abstract][Full Text] [Related]
53. Liver transplantation with grafts from donors who die from suicide by hanging: a matched cohort study.
Hoti E; Levesque E; Sebagh M; Heneghan HM; Khalfallah M; Castaing D; Azoulay D
Transplantation; 2014 Dec; 98(11):1236-43. PubMed ID: 24933455
[TBL] [Abstract][Full Text] [Related]
54. Isolated central nervous system recurrence in a child with stage IV neuroblastoma.
Sidi-Fragandrea V; Hatzipantelis E; Panagopoulou P; Fragandrea I; Anastasiou A; Koliouskas DE
Pediatr Hematol Oncol; 2010 Aug; 27(5):387-92. PubMed ID: 20469973
[TBL] [Abstract][Full Text] [Related]
55. Evaluation and application of donors with primary central nervous system tumors.
Wu JH; Qiao PF; Sun XY; Dong JH; Liao JX; Liu XY; Gao Z; Lan LG; Li HB; Su QD
Clin Transplant; 2019 Oct; 33(10):e13677. PubMed ID: 31342552
[TBL] [Abstract][Full Text] [Related]
56. The use of neoplastic donors to increase the donor pool.
Fiaschetti P; Pretagostini R; Stabile D; Peritore D; Oliveti A; Gabbrielli F; Cenci S; Ricci A; Vespasiano F; Grigioni WF
Transplant Proc; 2012 Sep; 44(7):1848-50. PubMed ID: 22974853
[TBL] [Abstract][Full Text] [Related]
57. Transplant tumor registry: donors with central nervous system tumors1.
Kauffman HM; McBride MA; Cherikh WS; Spain PC; Delmonico FL
Transplantation; 2002 Feb; 73(4):579-82. PubMed ID: 11889434
[TBL] [Abstract][Full Text] [Related]
58. Liver graft procurement in donors with central nervous system cancers.
Detry O
Liver Transpl; 2010 Jul; 16(7):914-5. PubMed ID: 20583288
[No Abstract] [Full Text] [Related]
59. Deceased donor liver transplantation from donors with central nervous system malignancy: Experience of the Inonu University.
Ince V; Ersan V; Ozdemir F; Barut B; Koc C; Isik B; Kayaalp C; Yilmaz S
North Clin Istanb; 2017; 4(3):213-217. PubMed ID: 29270568
[TBL] [Abstract][Full Text] [Related]
60. Rapid screening for safety of donation from donors with central nervous system malignancies.
Zhu M; Bian Y; Jiang J; Lei T; Shu K
Medicine (Baltimore); 2020 Dec; 99(49):e22808. PubMed ID: 33285676
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
